Profil
Cara Miller currently works at Tarsus Pharmaceuticals, Inc., as Senior Vice President-Corporate Affairs from 2023.
Ms. Miller also formerly worked at Portola Pharmaceuticals LLC, as Investor Relations Contact, Evofem Biosciences, Inc., as VP-Corporate Communications & Public Relations, and Vir Biotechnology, Inc., as Vice President-Corporate Communications.
Ms. Miller received her undergraduate degree from the University of Arizona.
Aktive Positionen von Cara Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2023 |
Ehemalige bekannte Positionen von Cara Miller
| Unternehmen | Position | Ende |
|---|---|---|
| EVOFEM BIOSCIENCES, INC. | Public Communications Contact | - |
| VIR BIOTECHNOLOGY, INC. | Public Communications Contact | - |
| PORTOLA PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Ausbildung von Cara Miller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Evofem Biosciences, Inc.
Evofem Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutic solutions to meet sexual and reproductive health needs of women | Health Technology |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
















